Tencent Cloud: Agent Memory 2.0.0 major version is now online, with a brand new upgrade to Team Memory.
The Tencent Cloud Agent Memory 2.0.0 major version has been launched, featuring an upgraded Team Memory that extends long-term memory capabilities from individuals to team collaboration scenarios.
On August 6, Tencent Cloud announced that the major version 2.0.0 of Tencent Cloud Agent Memory has been launched, with a completely upgraded Team Memory that extends long-term memory capabilities from individuals to team collaboration scenarios. In the future, the code knowledge, project documents, historical dialogues, and work methods generated during the team's collaboration with the Agent can all be consolidated into the team's long-term memory. This memory can be shared among different Agents and can be assembled according to the roles of the Agents and specific tasks, eliminating the need to reintroduce project backgrounds each time.
Tencent Cloud stated that if there are already GitHub code repositories, project documents, or historical Agent sessions, there is no need to start over. Team Memory supports the direct import of these existing assets and automatically generates the corresponding Wiki, CodeGraph, Chat Memory, and Skill, allowing Agents and team members to quickly take over existing projects.
Since its open-source release in May this year, TencentDB Agent Memory has attracted much attention from developers. Within 80 days of the project's open-source launch, the number of GitHub Stars has exceeded 15,000, and it has repeatedly topped the GitHub Trending daily rankings.
Related Articles

SINOPEC SEG (02386) plans to repurchase H-shares.

SINOPEC SEG (02386) will distribute an interim dividend of 0.127 yuan per share on October 30.

GenScript BIO (01548) released its mid-term results, with a shareholder loss of $129 million, narrowing by 29.25% year-on-year.
SINOPEC SEG (02386) plans to repurchase H-shares.

SINOPEC SEG (02386) will distribute an interim dividend of 0.127 yuan per share on October 30.

GenScript BIO (01548) released its mid-term results, with a shareholder loss of $129 million, narrowing by 29.25% year-on-year.

RECOMMEND





